The diagnosis and treatment of venous thromboembolism in asian patients

[1]  F. Klok,et al.  External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism , 2017, Thrombosis and Haemostasis.

[2]  M. Prins,et al.  Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. , 2016, The New England journal of medicine.

[3]  W. Ageno,et al.  Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE) , 2016, Thrombosis and Haemostasis.

[4]  S. Schulman,et al.  Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment , 2016, European Respiratory Journal.

[5]  Y. Nakajima,et al.  Evaluation of D-Dimer in Screening Deep Vein Thrombosis in Hospitalized Japanese Patients with Acute Medical Diseases/Episodes. , 2016, Annals of vascular diseases.

[6]  M. Prins,et al.  Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ , 2016, Thrombosis Journal.

[7]  P. Kuperan,et al.  A Practical Guide to Ordering and Interpreting Coagulation Tests for Patients on Direct Oral Anticoagulants in Singapore. , 2016, Annals of the Academy of Medicine, Singapore.

[8]  Masaaki Ito,et al.  Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy. , 2015, Journal of cardiology.

[9]  H. Büller,et al.  Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai‐VTE trial , 2015, Journal of thrombosis and haemostasis : JTH.

[10]  T. Fuji,et al.  Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V , 2015, Thrombosis Journal.

[11]  G. Raskob,et al.  Global public awareness of venous thromboembolism , 2015, Journal of thrombosis and haemostasis : JTH.

[12]  I. Komuro,et al.  Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study). , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[13]  H. Nakatsuka,et al.  The incidence of pulmonary embolism and deep vein thrombosis and their predictive risk factors after lower extremity arthroplasty: a retrospective analysis based on diagnosis using multidetector CT , 2015, Journal of Anesthesia.

[14]  Ching‐Jen Wang,et al.  Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial. , 2014, Thrombosis research.

[15]  A. Torbicki,et al.  Management of venous thrombo-embolism: an update. , 2014, European heart journal.

[16]  Yun-Jeong Lee.  Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients , 2014, Therapeutics and clinical risk management.

[17]  H. Büller,et al.  Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. , 2014, Blood.

[18]  T. Fuji,et al.  Safety and efficacy of edoxaban in patients undergoing hip fracture surgery. , 2014, Thrombosis research.

[19]  Gregory Y H Lip,et al.  Stroke prevention in atrial fibrillation: An Asian perspective , 2014, Thrombosis and Haemostasis.

[20]  Chien-Lin Liu,et al.  Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis. , 2014, Thrombosis research.

[21]  S. Goldhaber,et al.  Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis , 2014, Circulation.

[22]  E. Merriman,et al.  Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study , 2014, Journal of thrombosis and haemostasis : JTH.

[23]  C. Jung,et al.  Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines , 2014, Journal of Korean medical science.

[24]  M. Prins,et al.  Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies , 2013, Thrombosis Journal.

[25]  K. Bauer.  Pros and cons of new oral anticoagulants. , 2013, Hematology. American Society of Hematology. Education Program.

[26]  P. Wells,et al.  The diagnosis and treatment of venous thromboembolism. , 2013, Hematology. American Society of Hematology. Education Program.

[27]  G. Raskob,et al.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. , 2013, The New England journal of medicine.

[28]  G. Raskob,et al.  O R I G I N a L C L I N I C a L I N V E S T I G a T I O N Open Access , 2022 .

[29]  G. Raskob,et al.  Oral apixaban for the treatment of acute venous thromboembolism. , 2013, The New England journal of medicine.

[30]  Han-Jun Lee,et al.  The Incidence of Pulmonary Embolism and Deep Vein Thrombosis After Knee Arthroplasty in Asians Remains Low: A Meta-analysis , 2013, Clinical orthopaedics and related research.

[31]  B. Hiddinga,et al.  Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function , 2013, Journal of thrombosis and haemostasis : JTH.

[32]  A. Nicolaides,et al.  Asian venous thromboembolism guidelines: prevention of venous thromboembolism. , 2012, International angiology : a journal of the International Union of Angiology.

[33]  M. Kruip,et al.  Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism , 2012, Thrombosis and Haemostasis.

[34]  Sung-Soo Yoon,et al.  Managing venous thromboembolism in Asia: winds of change in the era of new oral anticoagulants. , 2012, Thrombosis research.

[35]  A. Earnest,et al.  Effectiveness of an algorithm in reducing the number of unnecessary ultrasound scans for deep vein thrombosis: an evaluation report. , 2012, Singapore medical journal.

[36]  G. Raskob,et al.  Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. , 2012, The New England journal of medicine.

[37]  E. Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[38]  Yngve Falck-Ytter,et al.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[39]  D. Cook,et al.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[40]  M. Samama,et al.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[41]  Michael K Gould,et al.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[42]  K. Bailey,et al.  Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. , 2011, Blood.

[43]  C. Sumanasrethakul,et al.  Systematic review and meta‐analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis , 2011, The British journal of surgery.

[44]  N. Zakai,et al.  Racial differences in venous thromboembolism , 2011, Journal of thrombosis and haemostasis : JTH.

[45]  P. Angchaisuksiri.  Venous thromboembolism in Asia – an unrecognised and under-treated problem? , 2011, Thrombosis and Haemostasis.

[46]  R. Gans,et al.  Oral rivaroxaban for symptomatic venous thromboembolism. , 2011, The New England journal of medicine.

[47]  Chien-Lin Liu,et al.  Deep vein thrombosis after total knee arthroplasty in asian patients without prophylactic anticoagulation. , 2011, Orthopedics.

[48]  S. Bang,et al.  Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database , 2011, Journal of thrombosis and haemostasis : JTH.

[49]  T. Fuji,et al.  Dabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients with a safety profile comparable to placebo. , 2010, The Journal of arthroplasty.

[50]  M. Margaglione,et al.  Population genetics of venous thromboembolism , 2010, Thrombosis and Haemostasis.

[51]  A. Cohen.  Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery , 2010, Thrombosis and Haemostasis.

[52]  Lisa Moores,et al.  Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. , 2010, Archives of internal medicine.

[53]  Y. Kao Yang,et al.  Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population , 2010, Journal of thrombosis and haemostasis : JTH.

[54]  K. Peter,et al.  New oral anticoagulant drugs in cardiovascular disease , 2010, Thrombosis and Haemostasis.

[55]  H. Horiguchi,et al.  Statistics for orthopedic surgery 2006–2007: data from the Japanese Diagnosis Procedure Combination database , 2010, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[56]  S. Goldhaber,et al.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism. , 2009, The New England journal of medicine.

[57]  M. Nozaki,et al.  Combined use of pretest clinical probability score and latex agglutination D-dimer testing for excluding acute deep vein thrombosis. , 2009, Journal of vascular surgery.

[58]  B. Heng,et al.  Venous thromboembolism at the National Healthcare Group, Singapore. , 2009, Annals of the Academy of Medicine, Singapore.

[59]  E. Grifoni,et al.  The role of D-dimer testing in patients with suspected venous thromboembolism. , 2009, Seminars in thrombosis and hemostasis.

[60]  T. Nakano,et al.  Venous thromboembolism: deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[61]  S. Uh,et al.  [Utility of D-dimer assay for diagnosing pulmonary embolism: single institute study]. , 2008, The Korean journal of laboratory medicine.

[62]  P. Moerloose,et al.  D‐Dimer for venous thromboembolism diagnosis: 20 years later , 2008, Journal of thrombosis and haemostasis : JTH.

[63]  M. Monreal,et al.  Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry , 2008, Thrombosis and Haemostasis.

[64]  Chung-Jen Chen,et al.  The value of D-dimer in the detection of early deep-vein thrombosis after total knee arthroplasty in Asian patients: a cohort study , 2008, Thrombosis journal.

[65]  N. Kakkar,et al.  Pulmonary Embolism in Medical Patients: An Autopsy-Based Study , 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[66]  Samuel Z Goldhaber,et al.  Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study , 2008, The Lancet.

[67]  S. Haas.  New oral Xa and IIa inhibitors: updates on clinical trial results , 2008, Journal of Thrombosis and Thrombolysis.

[68]  P. F. Adams,et al.  Health characteristics of the Asian adult population: United States, 2004-2006. , 2008, Advance data.

[69]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[70]  M. Nozaki,et al.  Uses of different D-dimer levels can reduce the need for venous duplex scanning to rule out deep vein thrombosis in patients with symptomatic pulmonary embolism. , 2007, Journal of vascular surgery.

[71]  C. Huerta,et al.  Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.

[72]  P. Romundstad,et al.  Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.

[73]  H. Büller,et al.  The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. , 2007, Chest.

[74]  Pamela K Woodard,et al.  Multidetector computed tomography for acute pulmonary embolism. , 2006, The New England journal of medicine.

[75]  Z. Jun,et al.  Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. , 2006, Clinical and laboratory haematology.

[76]  Pieter W Kamphuisen,et al.  Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. , 2006, JAMA.

[77]  A. Turpie,et al.  Deep‐vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography , 2005, Journal of thrombosis and haemostasis : JTH.

[78]  Roslyn A Stone,et al.  Derivation and validation of a prognostic model for pulmonary embolism. , 2005, American journal of respiratory and critical care medicine.

[79]  P. Rojnuckarin,et al.  Protein S deficiency is common in a healthy Thai population. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[80]  R. White,et al.  Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996 , 2005, Thrombosis and Haemostasis.

[81]  S. Goldhaber,et al.  Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients , 2004, Thrombosis and Haemostasis.

[82]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[83]  P. Mutirangura,et al.  Epidemiologic Analysis of Proximal Deep Vein Thrombosis in Thai Patients: Malignancy, the Predominant Etiologic Factor , 2004 .

[84]  G. Kovacs,et al.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.

[85]  M. Gent,et al.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[86]  Y. Gul,et al.  Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. , 2003, Asian journal of surgery.

[87]  R. White.  The Epidemiology of Venous Thromboembolism , 2003, Circulation.

[88]  K. Lau,et al.  Venous thromboembolism in the Chinese population--experience in a regional hospital in Hong Kong. , 2002, Hong Kong medical journal = Xianggang yi xue za zhi.

[89]  L. Lee.  Clinical update on deep vein thrombosis in Singapore. , 2002, Annals of the Academy of Medicine, Singapore.

[90]  G. Kovacs,et al.  Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer , 2001, Annals of Internal Medicine.

[91]  U. Seligsohn,et al.  Genetic susceptibility to venous thrombosis. , 2001, The New England journal of medicine.

[92]  Y. Kanakura,et al.  Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[93]  Han-Shiang Chen,et al.  Deep vein thrombosis after total knee arthroplasty. , 2000, Journal of the Formosan Medical Association = Taiwan yi zhi.

[94]  W. Tsay,et al.  Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. , 2000, Thrombosis research.

[95]  H. Hsu,et al.  Causes of venous thrombosis in fifty Chinese patients , 2000, American journal of hematology.

[96]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[97]  M. Prins,et al.  Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. , 1999, Archives of internal medicine.

[98]  M Gent,et al.  Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism , 1998, Annals of Internal Medicine.

[99]  J. Jeng,et al.  Aetiologies and prognosis of Chinese patients with deep vein thrombosis of the lower extremities. , 1998, QJM : monthly journal of the Association of Physicians.

[100]  A. Gori,et al.  Monitoring of low-molecular-weight heparins in cardiovascular disease. , 1998, The American journal of cardiology.

[101]  P. Reitsma,et al.  Geographic Distribution of the 20210 G to A Prothrombin Variant , 1998, Thrombosis and Haemostasis.

[102]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[103]  Janis Bormanis,et al.  Value of assessment of pretest probability of deep-vein thrombosis in clinical management , 1997, The Lancet.

[104]  B. Knight,et al.  Fatal pulmonary embolism: a comparative study of autopsy incidence in Hong Kong and Cardiff, Wales. , 1997, Forensic science international.

[105]  Tsu-Shiu Hsu,et al.  Deep venous thrombosis in Taiwan. , 1996, Japanese heart journal.

[106]  J. Hoak,et al.  Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. , 1996, Circulation.

[107]  K. S. Dhillon,et al.  Postoperative deep-vein thrombosis in Asian patients is not a rarity: a prospective study of 88 patients with no prophylaxis. , 1996, The Journal of bone and joint surgery. British volume.

[108]  R. Spinner,et al.  Compression of the Medial Half of the Deep Branch of the Ulnar Nerve by an Anomalous Origin of the Flexor Digiti Minimi. A Case Report* , 1996, The Journal of bone and joint surgery. American volume.

[109]  N. Dzimiri,et al.  World distribution of factor V Leiden , 1996, The Lancet.

[110]  Paolo Prandoni,et al.  Accuracy of clinical assessment of deep-vein thrombosis , 1995, The Lancet.

[111]  M. Samama,et al.  Contemporary laboratory monitoring of low molecular weight heparins. , 1995, Clinics in laboratory medicine.

[112]  J. Sixma,et al.  Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. , 1991, Blood.

[113]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[114]  J. Martin,et al.  Autopsy Proven Pulmonary Embolism in Hospital Patients: Are We Detecting Enough Deep Vein Thrombosis? , 1989, Journal of the Royal Society of Medicine.

[115]  J. Nerup,et al.  YERSINIA ENTEROCOLITICA INFECTION AND THYROID DISORDERS , 1974 .

[116]  V. Kakkar,et al.  Natural history of postoperative deep-vein thrombosis. , 1969, Lancet.

[117]  C. Lindsell,et al.  Randomized controlled trial , 2016 .

[118]  Yen-Hung Lin,et al.  Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. , 2016, Acta Cardiologica Sinica.

[119]  K. Komori,et al.  Current venous thromboembolism management and outcomes in Japan. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[120]  Jeroen J. Bax,et al.  ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[121]  M. Humbert,et al.  The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .

[122]  F. García-Bragado Dalmau.  [Oral Rivaroxaban for the treatment of symptomatic pulmonary embolism]. , 2013, Revista clinica espanola.

[123]  Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[124]  M. Raza.  Computed Tomographic Pulmonary Angiography vs Ventilation-Perfusion Lung Scanning in Patients With Suspected Pulmonary Embolism: A Randomized Controlled Trial , 2009 .

[125]  Cecilia Becattini,et al.  Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.

[126]  Piotr Pruszczyk,et al.  Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .

[127]  J. Douketis,et al.  Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. , 2006, JAMA.

[128]  C. Hirayama,et al.  Vascular Health and Risk Management Dovepress Postmarketing Safety Experience with Edoxaban in Japan for Thromboprophylaxis following Major Orthopedic Surgery , 2022 .

[129]  For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .